MedPath

Hytrin

Brand Name: Hytrin

Generic Name: Terazosin (as Hydrochloride)

Active
Registration Number

DRP-3676

Dosage Form

Tablet

Issuance Date

July 1, 2024

Expiry Date

August 11, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 mg
PackagingAlu/PVC/PVDC Blister Pack of 14's (Box of 28's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Alpha-Adrenoceptor Antagonist
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Terazosin (as Hydrochloride)Active
Monograph: Terazosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform